Alnylam Pharmaceuticals
ALNY
#584
Rank
HK$274.08 B
Marketcap
HK$2,135
Share price
-0.89%
Change (1 day)
55.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: HK$274.08 Billion

As of September 2024 Alnylam Pharmaceuticals has a market cap of HK$274.08 Billion. This makes Alnylam Pharmaceuticals the world's 584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024HK$274.08 B46.1%
2023HK$187.60 B-17.88%
2022HK$228.44 B44.45%
2021HK$158.14 B35.08%
2020HK$117.07 B16.34%
2019HK$100.63 B74.22%
2018HK$57.76 B-41.32%
2017HK$98.44 B295.12%
2016HK$24.91 B-59.87%
2015HK$62.08 B6.86%
2014HK$58.10 B82.81%
2013HK$31.78 B328.05%
2012HK$7.42 B174.53%
2011HK$2.70 B-16.74%
2010HK$3.24 B-43.18%
2009HK$5.71 B-27.98%
2008HK$7.93 B-14.22%
2007HK$9.25 B50.06%
2006HK$6.16 B208.73%
2005HK$1.99 B98.09%
2004HK$1.00 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

HK$274.08 Billion
by Yahoo Finance info icon info icon
HK$274.08 Billion
by CompaniesMarketCap info icon info icon
HK$274.08 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
HK$20.15 B-92.65%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$983.91 B 258.98%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$94.56 B-65.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.98 B-97.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.92 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.832 T 568.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$1.126 T 310.88%๐Ÿ‡ซ๐Ÿ‡ท France
HK$154.63 B-43.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel